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Abstract
Background: A rising number of people with chronic conditions is offered interventions to enhance self-management.
The responsiveness of individuals to these interventions depends on patient characteristics. We aimed to
develop and validate a tool to facilitate personalised counselling and support for self-management in patients with
chronic diseases in primary care.
Methods: We drafted a prototype of the tool for Self-Management Screening (SeMaS), comprising 27 questions that
were mainly derived from validated questionnaires. To reach high content validity, we performed a literature review
and held focus groups with patients and healthcare professionals as input for the tool. The characteristics self-efficacy,
locus of control, depression, anxiety, coping, social support, and perceived burden of disease were incorporated into
the tool. Three items were added to guide the type of support or intervention, being computer skills, functioning in
groups, and willingness to perform self-monitoring. Subsequently, the construct and criterion validity of the tool were
investigated in a sample of 204 chronic patients from two primary care practices. Patients filled in the SeMaS and a set
of validated questionnaires for evaluation of SeMaS. The Patient Activation Measure (PAM-13), a generic instrument to
measure patient health activation, was used to test the convergent construct validity.
Results: Patients had a mean age of 66.8 years and 46.6 % was female. 5.9 % did not experience any barrier to
self-management, 28.9 % experienced one minor or major barrier, and 30.4 % two minor or major barriers. Compared
to the criterion measures, the positive predictive value of the SeMaS characteristics ranged from 41.5 to 77.8 % and the
negative predictive value ranged from 53.3 to 99.4 %. Crohnbach’s alpha for internal consistency ranged from 0.56 to
0.87, except for locus of control (α = 0.02). The regression model with PAM-13 as a dependent variable showed that the
SeMaS explained 31.7 % (r2 = 0.317) of the variance in the PAM-13 score.
Conclusions: SeMaS is a short validated tool that can signal potential barriers for self-management that need to be
addressed in the dialogue with the patient. As such it can be used to facilitate personalised counselling and support to
enhance self-management in patients with chronic conditions in primary care.
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Background
The number of people suffering from one or more
chronic conditions is rising rapidly. In the Netherlands,
the percentage of patients that suffered from at least one
chronic disease raised from 12.6 % in 2003 to 15.0 % in
2009 [1]. Several studies have shown positive effects of
self-management programs on lifestyle and clinical out-
comes, as well as on patients’ motivation, cognition,
knowledge, engagement and activation related to self-
management behaviours [2–5]. Self-management is de-
fined as ‘the care taken by individuals towards their own
health and well-being: it comprises the actions they take
to lead a healthy lifestyle; to meet their social, emotional
and psychological needs; to care for their long-term con-
dition; and to prevent further illness or accidents’ [6].
However, realising effective self-management in daily
life is a major challenge for many people. Substantial
variation exists regarding the responsiveness of individ-
uals to self-management interventions [7, 8]. One of the
main reasons for the lack of success of self-management
interventions is that they often fail to address the
individual characteristics of the patient (i.e., personal
barriers, needs and situation that play a role in self-
management behaviour), resulting in suboptimal reach
and impact. The challenge is to find ways to enhance
the impact of self-management programs by persona-
lised counselling and support.
The concept of personalisation of treatment to individ-
ual characteristics has been introduced in other fields of
research, especially human genetics, where treatment is
tailored to genomic profiles. This is called personalised
medicine [9]. Similarly, in psychology treatment can be
adjusted to psychological characteristics of the patient
[10–12]. Personalisation has also been applied to web-
based interventions and printed material [13, 14]. We
applied the concept of personalisation on the application
of self-management interventions and hypothesised that
self-management counselling and support can be more
successful if a personalised approach is used.
Several studies have identified a single determinant of
patients’ self-management behaviour, such as self-efficacy,
depressive symptoms or coping behaviour [7, 15–17].
Self-efficacy is the patients’ perceived ability to overcome
difficulties in behavioural change. This is a predictor for
behavioural change, which is needed when confronted
with a chronic illness [18, 19]. Co-morbid depression is
often seen in patients with chronic diseases [20]. Depres-
sion negatively affects patients’ self-care [20]. Finally, cop-
ing refers to the way chronically ill patients cope with
problems they encounter. An active coping style positively
affects well-being and clinical outcomes [21].
It is essential to have a good understanding of the set
of individual characteristics that need to be considered
in personalised counselling and support of patients’ self-
management and how these characteristics can be mea-
sured in a valid and feasible way in a primary care set-
ting. There are some instruments available that measure
one or more aspects of self-management, often disease
specific, such as the Confidence in diabetes self-care
scale, or the Nijmegen Clinical Screening Instrument
(NCSI) for patients with Chronic Obstructive Pulmonary
Disease (COPD) [22, 23]. The NCSI questionnaire mea-
sures disease-specific characteristics that determine the
health status. The Self-Management Ability Scale
(SMAS) focuses on self-management ability of the eld-
erly in relation to well-being [24]. Other instruments
have been developed to assess the effect of self-
management interventions, such as the Health education
impact Questionnaire (heiQ), containing items on health
directed behaviour, attitude, self-monitoring and social
support [25]. The Partners in Health (PIH) scale and the
Patient Activation Measure (PAM-13) both measure the
current status of self-management, with items on e.g.
knowledge of the condition and skills to monitor
symptoms [8, 26].
However, to the best of our knowledge, no generic in-
strument exists that aims to measure patients’ character-
istics that could be a barrier for self-management, in
order to provide personalised counselling and support.
Moreover, no generic instrument exists that measures
these characteristics in a concise way with minimal re-
spondent burden. As with other patient-reported out-
come measures, minimising respondent burden is
important for the response rate and quality of the col-
lected data [27, 28]. Also, to make the tool practically
applicable to facilitate personalised counselling, results
should be presented in a way that is easy to interpret
and use in day-to-day care [28].
Relying on these insights, we aimed to develop and
validate a generic, brief and practically applicable self-
management screening questionnaire (SeMaS) to meas-
ure possible patient-related barriers to self-management
in chronic patients in primary care.
Methods
A step-wise, mixed methods approach was used to de-
velop and validate the SeMaS tool, as described below.
Table 1 provides an overview of the methods used per
type of validity. The research ethics committee of
Arnhem-Nijmegen reviewed the methods and question-
naires and waived approval.
Setting
The study was carried out in two primary care group
practices in the south of the Netherlands. These prac-
tices are a member of ‘De Ondernemende Huisarts’
(DOH), an innovative primary care group comprising 15
primary care group practices, and serving approximately
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110.000 patients. The care group provides integrated
healthcare for several chronic diseases, and has defined
self-management as a priority in their policy. The pro-
fessionals of this care group are all trained in the ‘actual
practice and maintenance’ approach, consisting of a be-
haviour change model (“series of steps”) and “individual
related factors” to enhance self-management [29]. The
“individual related factors” include the constructs locus
of control, self-efficacy, anxiety, depression, stress, cop-
ing style, styles of attribution, pain and somatisation.
These factors can be barriers for behavioural change.
Content validity and face validity
The content and face validity of SeMaS were based on a
literature review, focus group interviews with patients
and healthcare professionals, and pilot testing.
Literature review
Many publications report on one or two individual char-
acteristics that influence self-management behaviour. To
create an overview of possible important patient-related
characteristics, we performed a review in 2011 based on
a systematic literature search in the PubMed and psy-
cINFO databases, and screening of articles from the
years 2000 to 2011 on title and abstract. Due to time
constraints, we were not able to screen all full texts.
Therefore, of the 133 articles we screened all full texts
that described trials, controlled or comparative research,
and the most recent non-comparative, or qualitative re-
search. In total, 68 articles were screened, and from 42
full-text articles, all the characteristics that were named
in the articles were listed, as well as instruments used
for measurement. This review yielded a list of 43 items,
many of which overlapped. Examples were sex, age, per-
ceived burden of disease, and psychosocial factors such
as self-efficacy, social support and coping. Details of the
literature review are provided in Additional file 1.
Focus groups
Focus group interviews were held to document what pa-
tients and professionals considered important for
effective self-management based on their experience. A
purposeful sample of patients with chronic conditions
(the same patients participated in 3 focus groups; n = 10,
n = 6, n = 5) and primary care professionals (including
general practitioners, psychologist, dietician, physiother-
apist, nurse; 2 focus groups; n = 4, n = 5, one GP partici-
pated in both groups) participated in the focus groups.
The items from the literature review were used as input
in these interviews. The focus group interviews were
audio recorded, and field notes were made for identifica-
tion of the important characteristics. A report was made
of each focus group, which was sent to the participants
as preparation for the next session. Details of the focus
group interviews are described in Additional file 1. The
result of the focus group interviews was a preliminary
list of characteristics that should be incorporated in the
tool, according to the patients and professionals.
Stakeholder group
The development of the tool was guided by a group of
stakeholders, consisting of two general practitioners, a
psychologist, a nurse, three researchers, and two health-
care innovation experts of two health insurance com-
panies. After completing the focus group interviews, the
stakeholder group made the final selection of character-
istics to be incorporated in the tool, as described below.
Also, the stakeholder group monitored whether the
study was conducted as planned.
Prototype questionnaire
Combining the results of the literature study with those
from the focus groups, the stakeholder group selected
the characteristics that should be incorporated in the
tool, as shown in Table 2. Considering the application in
a primary care setting, we wished to develop a short,
user-friendly tool, which could be used across chronic
conditions and types of patients. Characteristics were se-
lected if a) the characteristic was named in the focus
group interviews, b) we found scientific evidence in the
literature study that this characteristic influenced self-
management, and c) a validated tool was available to
Table 1 Overview of methods used for validation of SeMaS
Type of validation Method
Content validity Literature review
Focus group interviews
Face validity Focus group interviews
Stakeholders group
Criterion validity Calculation of PPV, NPV and correlations of SeMaS using the validated
questionnaires as ‘golden standard’
(Convergent) Construct validity (hypothesis testing) Correlation of SeMaS with PAM-13
Reliability: internal consistency Crohnbach’s alpha
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measure the characteristic. A few exceptions were made.
Age (date of birth) and education, known predictors of
health literacy, were already incorporated in the ques-
tionnaire to gather demographic data. Therefore, health
literacy, the ability to read and understand things people
commonly encounter in the healthcare setting, was not
incorporated in the tool, as to reduce the length of the
questionnaire [30]. Sense of self-esteem and confidence
in self-care were two characteristics similar to self-
efficacy, and were therefore not incorporated in the tool.
Two additional constructs were incorporated in the tool.
Locus of control, the belief of a person that the attain-
ment of a certain outcome is within (internal locus) or
outside (external locus) their own control, was men-
tioned in the focus group interviews and the stake-
holders group [19]. Anxiety was also mentioned in the
stakeholders group, as a characteristic that has impact
on self-management. Therefore, anxiety and locus of
control were incorporated in the tool.
Next, we developed a prototype of the questionnaire
to test in practice. For the selected characteristics, we
used items from validated questionnaires, which we
identified in the literature review, further targeted
searches on the Internet, or consultation of experts in
the stakeholders group. The items were selected, consid-
ering the psychometric features of the questionnaire if
available. Otherwise, items were selected based on face
validity, as described in the Measures section. Specific-
ally, the research team discussed whether the selected
items would suffice to cover all aspects of the construct
being measured. For uniformity in the newly developed
SeMaS questionnaire, the wording of some items in
SeMaS was slightly altered. For example: all items were
formulated in I-form instead of the you-form. We also
slightly adjusted the response scales to make it as uni-
form as possible, and thus easier for the patient to fill
out the questionnaire. For example, the response scale of
self-efficacy was reduced from a 7 point to a 4 point
Likert scale, and still ranging from completely false to
completely true. Also, one option was added to the re-
sponse scale of coping, ranging from never to very
often/continuously, to correspond with the anxiety and
depression subscales. However, when scoring these
items, the extra option for coping (‘often’) received the
same score as the option ‘very often/continuously’. As a
result, all questions of SeMaS had a 4 or 5 point Likert
scale, except perceived burden of disease. This item was
scored on a visual analogue scale from 0 to 10. The ori-
ginal questionnaires are provided in Additional file 2. To
enhance the content validity, the stakeholders group
assessed the prototype, leading to some minor adapta-
tions. Three items were added to guide the type of sup-
port or intervention, being computer skills, functioning
in groups, and willingness to perform self-monitoring.
Pilot testing
Before starting the observational study, we tested the
prototype SeMaS questionnaire on a small scale. The
readability and feasibility in general practice were pre-
tested in the third focus group with patients. After
minor textual adjustments, the questionnaire was tested
in two group practices of the DOH care group. Twenty-
four patients with chronic conditions participated while
waiting for their consultation with the practice nurse.
Table 2 Selection of characteristics for the SeMaS questionnaire
Patient characteristics
identified in literature review
Mentioned in focus group interviews
with professionals and/or patients








Educational level Yes 1, 2 Yes Yes 1
Sex Yes 2 Yes Yes 1
Age Yes 2 Yes Yes 1
Perceived burden of disease Yes 2 Yes (inverse) Yes 1
Self-efficacy Yes 1, 2 Yes Yes 2
Social support Yes 1, 2 Yes Yes 1 (6 subitems)
Depression/depressive
symptoms
Yes 1, 2 Yes Yes 3
Health literacy Yes 2 Yes No -
Coping Yes 2 Yes Yes 9
Sense of self esteem Yes 2 No No -
Confidence in self care Yes 2 No No -
Locus of control Yes - Yes Yes 2
Anxiety No (added by stakeholders) - Yes Yes 4
Level of scientific evidence: 1 = comparative research; 2 = non-comparative, or qualitative research. Only characteristics that were named in the focus groups or
stakeholder group and that were included in the questionnaire are shown here. See Additional file 1 for the entire list of characteristics found in the literature
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Patients received information about the study, and in-
formed consent was obtained. Patients were asked to fill
in the questionnaire. Results were displayed in a graphic
profile; a visual representation of the scores on SeMaS,
as displayed in Fig. 1. With this profile, the healthcare
professional is able to see the results at a glance. This
profile was discussed with the patient during the consult.
After the consultation, interviews were held with the pa-
tients to identify problems with the readability and feasi-
bility of the questionnaire, resulting in some small
textual adjustments to the questionnaire. Also, the effect
of discussing the profile during the consult was evalu-
ated during the interview.
Interpretability
We wanted to provide the results of SeMaS in a graphic
profile that can be easily used and interpreted by the
healthcare professional in day-to-day care. For each
characteristic, a score was calculated by adding up the
scores of the individual items. These scores were cate-
gorised and presented in a graphic profile in terms of
barriers for self-management: no, minor, or major bar-
riers. For anxiety and depression, the categorisation was
in line with the original questionnaire, where the cat-
egories no, minor and major elevation were used based
on the sum scores. For locus of control and coping, the
categorisation in the type of locus (internal or external)
or coping style (problem solving, expressing emotions or
looking for distraction) was used. No categorisation was
available for perceived burden of disease, self-efficacy,
and social support. Therefore, categorisation was based
on face validity. For perceived burden of disease, a low
burden (0–2) was classified as a possible minor barrier
for self-management, as the motivation for behavioural
change could be low. On the other hand, a high burden
of disease (8–10) could hinder self-management due to
e.g. functional impairments, and thus also classified as
minor barrier. Scores 3 to 7 were classified as no barrier.
The responses for the two items on self-efficacy were
scored from 0 to 3, thus having a maximum sum score
of 6. The scores 4 to 6 were classified as having high
self-efficacy and thus no barrier, 2 to 3 as a minor bar-
rier, and 0 to 1 as major barrier.
For social support, the responses ‘no’, ‘completely false’
and ‘somewhat false’ were scored as 0; ‘somewhat true’
as 1, and ‘completely true’ as 2. Total score for this cat-
egory was 12. The scores 3 to 12 were categorised as
having no barrier (thus having 2–3 persons in the pa-
tients’ network who can provide support), 2 was cate-
gorised as having a minor barrier, and 1 to 0 as having a
major barrier.
Although developed separately, the SeMaS question-
naire and the ‘actual practice and maintenance approach’
overlapped substantially in patient characteristics that
were included for their importance for self-management,
such as self-efficacy, social support, anxiety, depression,
coping and locus of control [29]. Therefore, a manual
was developed for the practice nurses to guide the inter-
pretation and use of this information, based on the ‘ac-
tual practice and maintenance approach’ [29]. Both the
categorisation and manual were developed in collabor-
ation with the developer (author FV) of this approach.
Construct and criterion validity
The construct and criterion validity of the SeMaS tool
were tested in an observational study with a sample of
patients from two general practices.
Fig. 1 Example of the SeMaS graphic profile as a representation of the scores on SeMaS
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Study population
The patient sample comprised patients visiting two
group practices from the care group. Patients with a
chronic disease (diabetes mellitus, COPD, asthma, and/
or (high risk for) cardiovascular disease) who were
treated for this condition in primary care by a practice
nurse, and were over 18 years of age were eligible to par-
ticipate in the study. The chronic conditions were coded
according to the International Classification of Primary
Care (ICPC) in the medical health records.
To test the practicality of the instrument, practice
nurses were asked to discuss the results of SeMaS with
the patients in planned consultations. To simulate the
normal procedure in the primary care practice, patients
were selected from the agenda of the practice nurse. As
many patients as possible were selected per day in a five
month period, while not selecting on other patient char-
acteristics, besides the inclusion criteria. 243 patients
responded to the invitation to participate in the study.
Patients were invited to complete the questionnaire
and return it in a prepaid envelope to the research insti-
tute, together with the signed informed consent form.
The questionnaire consisted of the SeMaS, and a set of
validated questionnaires to evaluate SeMaS, as described
in the ‘Measures’ section.
Measures
SeMaS
The SeMaS questionnaire that was tested contained 27
items in total, measuring the psychological constructs
self-efficacy (2 items), coping (6 items), depression (3
items), anxiety (4 items) and locus of control (2 items)
[18, 19]. The construct of social support included 5
items [31]. Also, the perceived burden of disease was
assessed (1 item). Three other items that guide the type
of support concerned computer skills, functioning in
groups and willingness to perform self-monitoring (3
items). The questionnaire was made available in the
Dutch language.
Criterion validity
To determine the criterion validity of the SeMaS, we
assessed whether the scores on the SeMaS were an ad-
equate reflection of the scores on the original validated
instruments. For this purpose, patients were asked to fill
in these original instruments. The original instruments
and the items used in SeMaS are described below. The
original instruments were used in their original form.
Self-efficacy
In the SeMaS questionnaire, two out of four items from
the perceived competence scale were used to determine
the level of self-efficacy, based on face validity [19, 32, 33].
To improve uniformity in the SeMaS questionnaire, we
adjusted the response categories of the original question-
naire from a 7-point to a 4-point Likert scale, ranging
from completely false to completely true . Items were
translated from English to Dutch by the research team.
For assessing the criterion validity of the characteristic
self-efficacy, two questions from the Dutch version of the
Patient Activation Measure (PAM-13) were used in the
analysis, as these items were very similar, and were already
assessed for construct validity [8, 34]. The PAM-13 mea-
sures knowledge, skills and self-efficacy for self-
management [8].
Coping
For coping, we used the Dutch version of the short
Utrecht Coping List (UCL-k) [18, 35]. This question-
naire consists of 14 items, with a 4-point response scale
ranging from never to very often/continuously. Respon-
dents indicate how often they cope with problems in a
certain way. The questionnaire distinguishes three cop-
ing styles, being problem solving (P), expressing emo-
tions (E) and looking for distraction (D). Based on
correlations between the items from available research
data from 183 carers for patients with dementia, we used
two items per coping style in the SeMaS questionnaire,
thus six items in total. The wording of the items was
slightly altered to the I-form, and the response categor-
ies adjusted to the 5-point scale of the anxiety and
depression subscales.
Anxiety and depression
For anxiety and depression, we used these subscales of
the validated Dutch version of the 4-dimensional symp-
tom questionnaire (4DSQ). The 4DSQ is a self-report
questionnaire of 50 items that measures non-specific
general distress, depression, anxiety and somatisation,
with a 5-point response scale ranging from never to very
often/continuously [36]. Using available data from 2127
patients in general practice [36], we computed correla-
tions between the items, and removed items that had a
correlation >0.7 with another item. For anxiety, we used
4 from the original 12 items. For depression, we used 3
from the original 6 items. The wording of the questions
was slightly changed to the I-form. Response categories
were not altered.
Locus of control
We used the Dutch version of the Multidimensional
Health locus of control scale (MHLCS) for locus of con-
trol [19, 37]. The MHLCS consists of 18 questions with
a 6-point Likert-scale, ranging from completely disagree
to completely agree. The MHLCS identifies three orien-
tation scales, being: physician orientation, chance orien-
tation, and internal orientation. Sum scores are
produced per scale. The scale with the highest score is
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the most prevalent one. In the SeMaS questionnaire we
dichotomised the locus of control sum score into an in-
ternal orientation versus an external orientation (phys-
ician and chance), consistent with the “actual practice
and maintenance” approach [29]. We used two MHLCS
items in SeMaS that most clearly represented the in-
ternal and external orientation. The items were chosen
on face validity, as no data was available to us. The re-
sponse categories were reduced to a 4-point Likert-scale
for uniformity in the SeMaS.
Social support
For social support, the Short Scale of Social Support
(SSSS) was used. This questionnaire consists of 5 items
and measures actual support in case of need [38]. One
item on the support from neighbours was added, as this
was relevant for the Dutch context. The response cat-
egories were adjusted to match the subscales of self-
efficacy and locus of control for consistency from helpful
(not at all-completely) to completely disagree/agree
(both 4-point Likert scale). Items were translated from
English to Dutch by the research team.
Perceived burden of disease
For perceived burden of disease, the Dutch version of
the EQ-5D questionnaire was used, containing five di-
mensions of quality of life, and one item on the per-
ceived health status [39]. The item on the perceived
health status was used in the SeMaS, and inversely for-
mulated to measure the perceived burden of disease.
The item was scored on a visual analogue scale from 0
to 10 (0 to 100 in EQ-5D), as this is a concise way of
measuring subjective characteristics.
Convergent construct validity
Hibbard et al. developed a short questionnaire to meas-
ure the level of patient activation, the PAM-13 [8]. This
questionnaire assesses patient knowledge, skills, and
self-efficacy for self-management [8]. The PAM-13 is
one of the few generic measures for the level of self-
management. We obtained permission of Insignia to use
the PAM-13 in this study.
We used the validated Dutch version of PAM-13 to
determine the convergent construct validity, hypothesis-
ing that the better the score on the SeMaS (i.e. having
fewer barriers to self-management), the higher the score
on PAM-13 [34]. We obtained permission of Insignia to
use the PAM-13 in this study.
Data-analysis
Descriptive analysis was used to inspect the distributions
of scores and numbers of missing values on items in the
SeMaS questionnaire. When computing sum scores for
each construct, cases with missing values were excluded,
except for social support. In the SeMaS and the Short
Scale of Social support the missing values were inter-
preted as ‘not applicable’.
The internal consistency was determined for each
construct in SeMaS using Crohnbach’s alpha. Values
of 0.6–0.7 are considered acceptable; 0.7 or higher is
considered as good [40].
To determine the criterion validity, the positive (PPV)
and negative predictive value (NPV) of the characteris-
tics in SeMaS were determined regarding the scores on
the (more comprehensive) original questionnaires. The
positive predictive value (PPV) indicates the percentage
of rightly detected barriers by SeMaS, compared to the
original questionnaire. The PPV is calculated by dividing
the number of patients with a barrier for self-
management detected by SeMaS and the original ques-
tionnaire, by the total number of patients with a barrier
detected by SeMaS. The negative predictive value (NPV)
indicates the percentage of rightly indicated absence of
barriers by SeMaS, compared to the original question-
naire. The NPV is calculated by dividing the number of
patients with no barrier detected by SeMaS and the ori-
ginal questionnaire, by the total number of patients with
no barrier detected by SeMaS. We considered the PPV
and NPV as relevant measures for application of the
SeMaS tool in everyday practice [41, 42]. Also, correla-
tions of the sum scores of each construct in SeMaS with
the sum scores on the original questionnaire were com-
puted to investigate the relationship between both mea-
sures. Values of 0.3 to 0.7 indicate a moderate linear
relationship; 0.7 or higher indicate a strong linear rela-
tionship. For validation purposes, a correlation of 0.7 is
recommended [43]. We checked whether the sum scores
were normally distributed. In case of a normal distribu-
tion, we used Pearson’s r, otherwise the non-parametric
Spearman’s rho.
PAM-13 was used to determine the construct validity
of the SeMaS based on convergent validity. In a regres-
sion analysis, categorical variables should consist of two
categories. Therefore, in the regression analysis, we
dichotomised the scores on SeMaS into having no bar-
rier versus having a (minor or major) barrier. Using uni-
variate ANOVA, all constructs were tested on whether
the PAM scores differed between the categories. Subse-
quently, using multivariate linear regression models, the
relations between the relevant SeMaS characteristics and
PAM scores (0–100) were investigated. We performed
all analyses using SPSS software (version 20, IBM Corp.).
We performed the aforementioned analyses as primary
analyses. Based on the findings in the primary analyses,
the tool was adjusted to its final version as a last step in
the validation process. After the final adjustments, we
performed the secondary analyses. The final instrument
is added in Additional file 3, as well as the calculation of
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the scores. The results of the primary analyses are shown
in Additional file 4. Also, the final adaptations are de-
scribed in this additional file. Here, we present the re-
sults of the secondary analyses, as these represent the
test characteristics of the instrument in its actual form.
Results
Of the 243 eligible patients, 204 returned the question-
naire (response rate: 84 %). Of the respondents, 53.4 %
was male, with an average age of 66.7 ± 9.1 years, and
46.6 % was female, with an average age of 66.9 ± 9.6 years
(Table 3). Most of the participants had multiple ICPC
codes for (risk of) chronic conditions. The ICPC codes
for (risk of ) cardiovascular disease was present for 92.6
and 91.7 % of the male and female participants, respect-
ively. Of the male participants, 16.2 % had a diagnosis of
diabetes mellitus, while 35.4 % of the female participants
had this diagnosis. The ICPC codes for asthma/COPD
were found in 12.0 % of the male participants, and
19.8 % of the female participants. No data was available
on the non-responders, as these patients did not give
their consent for the study.
The number of missing values per characteristic in
SeMaS ranged from 3 (self-efficacy) to 64 (coping). For
social support, 101 cases had missing values on the indi-
vidual items. One case was excluded, which had no valid
responses on the items for social support. Cases were
excluded from the analysis if they had missing data for
the construct being analysed.
In Fig. 2, the distribution of the scores on SeMaS on
the psychosocial characteristics and perceived burden of
disease is displayed. On separate characteristics, 1.0 to
17.4 % of the patients showed major barriers, and 3.0 to
51.2 % showed minor barriers, according to the SeMaS
scores. Only 5.9 % of the patients showed no barrier on
any of the characteristics. 28.9 % had one minor or
major barrier. This is shown in Table 4.
Criterion validity
In Table 5, the PPV, NPV and correlation of SeMaS with
the sum scores on the original questionnaires are dis-
played. The PPV and NPV are based on the categories
on each characteristic. The PPV ranged from 41.5 to
77.8 %, and the NPV from 53.3 to 99.4 %. Crohnbach’s
alpha (α) ranged from 0.56 to 0.86, except for locus of
control (α = 0.02). For anxiety (α =0.56) and coping (sub-
type: looking for distraction; α =0.56), Crohnbach’s alpha
was just below the acceptable range. Crohnbach’s alpha
(α) was within the acceptable range (0.6–0.7) for social
support (α =0.63), and good (>0.7) for self-efficacy (α
=0.86), coping (subtypes: problem solving (α =0.70),
emotional (α =0.73)), and depression (α =0.87). Correla-
tions of SeMaS sum scores with the original question-
naires ranged from 0.418 to 0.805. Self-efficacy, (0.418,
p < 0.01), anxiety (0.653, p < 0.01), locus of control
(0.472, p < 0.01), social support (0.626, p < 0.01), and per-
ceived burden of disease (0.554, p < 0.01) showed a mod-
erate correlation with the original questionnaires.
Coping (0.746; 0.800; 0.783, p < 0.01) and depression
(0.805, p < 0.01) showed a strong correlation with the
original questionnaires. Spearman’s rho was computed
for self-efficacy, depression, anxiety, social support and
perceived burden of disease, since the sum scores of
these characteristics were not normally distributed.
Construct validity
All psychosocial characteristics and perceived burden of
disease from the SeMaS showed significant different
PAM-scores between the SeMaS categories (no versus
minor/major barrier), except coping. These characteris-
tics were used in the regression analysis. With the PAM
scale as dependent variable, the forced entry regression
showed that these psychosocial characteristics together
explained 31.7 % (r2 = 0.317) of the variance in the PAM
score. The β of the separate characteristics varied
from 0.04 for depression (p = 0.990) to 16.43 for self-
efficacy (p <0.001), as displayed in Table 6. Social
support (p = 0.032) and self-efficacy (p <0.001) con-
tributed significantly to the model. The β values for
these characteristics indicated that patients without a
barrier for self-efficacy scored 16.43 points higher on
the PAM than patients with a barrier. Similarly, patients
without a barrier for social support scored 6.64 points
higher on the PAM.
Table 3 Description of the study population (numbers (%))
Male Female
Number of respondents 109 (53.4 %) 95 (46.6 %)
Age in years (mean ± SD) 66.7 ± 9.1 66.9 ± 9.6
Education
- No education 0 (0 %) 3 (3.2 %)
- Lower education 18 (16.5 %) 31 (32.7 %)
- Middle education 43 (39.4 %) 27 (28.4 %)
- Higher education 42 (38.6 %) 20 (21.0 %)
- Other 1 (0.9 %) 6 (6.3 %)
- Missing 5 (4.6 %) 8 (8.4 %)
Chronic illness
- Diabetes 49 (16.2 %) 34 (35.4 %)
- CVRM 100 (92.6 %) 88 (91.7 %)
- Asthma/COPD 13 (12.0 %) 19 (19.8 %)
- Other 3 (2.8 %) 6 (6.3 %)
- Missing 2 (1.9 %) 0 (0 %)
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Discussion
This manuscript describes the validation of SeMaS using
a mixed methods approach. We aimed at developing a
short screening questionnaire that is applicable in day-
to-day care by practice nurses in a primary care setting.
The instrument is now ready for testing of its impact in
every day practice.
The analyses for criterion validity showed reasonable
to good results, with values for NPV and PPV that are
comparable to or better than other diagnostic tests in
primary care [44–46]. Most patients showed barriers for
coping and locus of control. The majority of the partici-
pants did not experience any anxiety or self-efficacy bar-
riers. The PPV and NPV are dependent on the
prevalence of the barriers. A low prevalence causes a
low PPV, even when the sensitivity and specificity of the
test are good. This could be the case for anxiety, as only
4.9 % of the patients had a barrier detected by SeMaS,
and the PPV was on the low side. Thus, SeMaS could be
sufficiently able to detect barriers on anxiety, while this
is not reflected in the PPV value.
Furthermore, the values of Crohnbach’s alpha for in-
ternal consistency are in the acceptable range for most
of the characteristics. The value of Crohnbach’s alpha
depends on the length and heterogeneity of the con-
struct being measured [47]. This could explain the lower
values for the characteristics locus of control, social sup-
port and anxiety. These constructs are heterogeneous,
e.g. for anxiety several types of anxiety complaints are
measured: irrational fears, anticipation, anxiety and
avoidance behaviour [36].
For locus of control, both the Crohnbach’s alpha and
correlations are low. This could be due to the concise
way of measuring this characteristic in the SeMaS, as we
decreased the number of items from 18 in the original
questionnaire to two items in the SeMaS. Literature on
this characteristic showed that the scientific evidence of
the impact of locus of control on self-management is in-
conclusive [15, 48]. Therefore, further validation and re-
search on this characteristic is recommended.
The SeMaS is developed with the explicit aim to
contain only a limited number of questions to enable
its feasibility in daily practice. Depending on the cut-
off points of the categories, more false positive or
more false negative cases will be detected. We defined
the cut-off points realising that the instrument opens
up the opportunity to find barriers otherwise at all
undetected. The SeMaS is intended as a tool to signal
potential barriers for self-management that need to be
addressed in the conversation with the patient, rather
than as a diagnostic tool.
Depression and anxiety are important possible barriers
for self-management [49], and often undiagnosed by the
general practitioner [50–52]. SeMaS helps in detecting
these problems. If indicated, additional diagnostic instru-
ments should be used for anxiety and depression.
To test whether the tool was practically applicable,
practice nurses were asked to discuss the results of

























Fig. 2 Scores of the study population on the psychological characteristics and social support of SeMaS. The category ‘minor barrier’ of coping
includes patients that had multiple coping styles (21.7 %). Perc. burden: perceived burden of disease

















Eikelenboom et al. BMC Family Practice  (2015) 16:165 Page 9 of 12
the observational study. In evaluative interviews, the
practice nurses indicated the tool as practical and useful
in practice, although they needed time to learn to work
with the tool (findings available upon request).
The SeMaS scores explained part of the variance in
the PAM-13 scores. The main part of this explained
variance could be attributed to the shared characteristic
of both instruments, being self-efficacy. As PAM-13 fur-
ther measures knowledge and skills (related to manage-
ment of the disease, and not related to possible
interventions), which are not incorporated in the SeMaS,
it is understandable that not all variance in the PAM
scores can be explained by the SeMaS. Nevertheless
we chose PAM-13 as a reference, since it is one of
the few generic measures for the level of self-
management at this time.
As discussed in the introduction, there are a few other
instruments that show some overlap with the SeMaS.
These instruments assess disease-specific characteristics
(NCSI), or focus on the current level of self-
management (PIH, PAM-13) [8, 26, 53]. The difference
between these instruments and SeMaS is that SeMaS is
a generic instrument that assesses person-related charac-
teristics that could be a barrier for self-management of a
chronic condition. By assessing these characteristics and
presenting the results in a graphic profile, SeMaS can be
used to provide personalised counselling and support.
Strengths and limitations of this study
SeMaS was systematically developed, using a range of
methods. Based on the input from the focus group inter-
views and the stakeholder group much effort was put in the
uniformity of the questionnaire regarding wording of the
items and response categories. In the first analyses the
rephrasing of various items showed to be a factor with
negative influence on the PPV and the NPV. For this reason
we decided to adjust the wordings more in line with the
original questionnaires, as described in Additional file 4. A
further strength of this study was that the response of the
selected sample was high (>80 %), decreasing the risk of at-
trition bias. Also, the minimal number of respondents (150)
for a validation study was well achieved. Another strength
of this study could be that the participating primary care
practices are part of an innovative care group, which has
formulated a policy agenda on self-management. This may
have influenced the development of the instrument in a
positive way, as the participating patients and professionals
may have been more experienced in what characteristics
could hinder self-management. Furthermore, the fact that
patients and health care professionals were involved in the
development of this instrument increases the possibility of
the instrument being applicable in practice.
A limitation of this study is that the literature study
comprised a systematic search, and screening of all ab-
stracts for inclusion, but review of a subset of the full
text articles. Since many characteristics were mentioned
in multiple articles, and the characteristics that are im-
portant for self-management were also discussed in the
focus group interviews, we felt we captured the most
important characteristics that had to be incorporated in
the tool.
Another limitation of this study could be that the
participating primary care practices are part of an in-
novative care group, with a policy agenda on self-
management. Possibly, the issues raised by the patients
and professionals in the focus groups differ from issues
in other care groups. This may have implications for use
in practice, as other care groups less experienced with
stimulating self-management may not recognise the
Table 5 Description of the psychometric characteristics of the
final SeMaS





score on SeMaS with
sum score on original
questionnaire
Self-efficacy 182 57.1 79.8 0.86 0.418**a
Coping 171 41.5 94.4 0.70 0.746** (P)
0.73 0.800** (E)
0.56 0.783** (D)
Depression 192 67.9 99.4 0.87 0.805** a
Anxiety 182 77.8 91.3 0.56 0.653** a
Locus of control 147 67.6 53.3 0.02 0.472**
Social support 191 N.A. N.A. 0.63 0.626**a
Perceived
burden of disease
163 N.A. N.A. N.A. 0.554**a
PPV percentage of patients with a barrier on SeMaS that has a barrier
according to the original questionnaire
NPV percentage of patients with no barrier on SeMaS that has no barrier
according to the original questionnaire
N. A. not applicable
Coping styles: (P) problem solving; (E) emotional; (D) distraction
a correlation: spearman’s rho; sum scores were not normally distributed
* p < 0.05; ** p < 0.01
Table 6 Results of the regression model with PAM-13 as the
dependent variable
Parameter β SE β Standardised β p
Intercept 34.50 0.000
Locus of control 2.99 2.18 0.10 0.173
Anxiety 0.84 4.97 0.10 0.866
Depression 0.04 3.46 <0.01 0.990
Social support 6.64 3.06 0.16 0.032
Self-efficacy 16.43 2.82 0.46 <0.001
Perceived burden of disease 3.51 2.11 0.12 0.098
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incorporated characteristics as important, or may have
less possibilities in providing personalised support.
Conclusions
The SeMaS questionnaire has been developed and vali-
dated in this study. The SeMaS is now ready for testing
in practice as a generic, brief, practically applicable tool
to measure possible patient-related barriers to self-
management in chronic patients in primary care.
The results of this study show that it is possible to cre-
ate profiles of patients regarding their self-management
competence. Next, we will investigate the applicability
and the impact of the use of these profiles in counselling
on self-management in primary care [54]. Using the pro-
files to provide personalised self-management support
may positively influence the effectiveness of the support
and self-management interventions. This next study will
also provide possibilities for further validation of the
SeMaS questionnaire.
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